Mizuho Cuts Align Technology (ALGN) Price Target to $200
Key Points
- Mizuho reaffirmed its Outperform rating on Align Technology, Inc. on October 22, 2026, while lowering its price target to $200.0 from $220.0.
- Mizuho's $200 price target implies 32.13% upside from Align Technology, Inc.'s ($ALGN) current $151.37 share price.
- The medical device maker recently traded around $151.37, sitting below its 50-day moving average of $152.88 and its 200-day moving average of $169.40.
- Wall Street firms have actively reviewed the stock ahead of its upcoming earnings report, with Stifel, Leerink Partners, Baird, and Piper Sandler updating targets in October 2026.
Get Align Technology text alerts
We text you when insiders, Congress, analysts or big funds move on $ALGN.
By entering your mobile number and tapping the sign-up button, you provide express written consent to receive recurring automated text messages from TradeTexts at that number, including stock alerts about SEC filings, insider and congress trades, analyst ratings, hedge fund moves, and earnings results. Consent is not a condition of any purchase. Message frequency varies. Messages are not investment advice. Message and data rates may apply. Reply HELP for help and STOP to opt out at any time. See our Terms and Privacy Policy.
Not investment advice. TradeTexts is not a registered investment adviser, and this automated Align Technology, Inc. alert may contain errors. Disclosures
Mizuho reaffirmed its Outperform rating on Align Technology, Inc. (ALGN) on October 22, 2026, while adjusting its price target down to $200.0 from $220.0. The stock closed at $154.16 on the day of the announcement.
ALGN
Align Technology, Inc.
Mizuho vs. the S&P 500
Hypothetical returns from Mizuho's disclosed trades, not real profit or advice. How we model this.
Mizuho's Call on Align Technology
In its research note issued on October 22, 2026, Mizuho kept an Outperform rating on the medical device maker while lowering the target from $220.0 to $200.0. Even with the reduced target, the new figure sits well above where shares have recently changed hands.
Other Institutional Activity in Align Technology
Capital International Investors grew its holdings by 236,182 shares, ending with 4,045,561 shares worth about $623,683,884. Ninety One UK Ltd reduced its stake by 76,240 shares, ending with 2,133,621 shares valued at roughly $328,929,667.
Align Technology, Inc. Stock Holds Steady
Align Technology recently traded around $151.37 as of October 22, 2026, down about 1.8% from its event close of $154.16. The stock sits below its 50-day moving average of $152.88 and its 200-day moving average of $169.40. Shares have traded in a 52-week range between $130.23 and $200.44.
$ALGN price target
Align Technology, Inc. daily closes and this analyst's $200 target. Not advice.
Recent Earnings
For the trailing twelve months, Align Technology generated $4,139,532,032.0 in revenue with earnings of $5.75 per share. The company reported a net profit margin of 10.0% and a return on equity of 10.2%. The next earnings report is scheduled for October 28, 2026.
Earnings drift grade
Outlook vs expectations on the last report — not price action.
-
Forward outlook
1 analysts raised price targets.
-
EPS & revenue
EPS beat estimates by 11.0%. Revenue met estimates.
-
Profit surprise
EBITDA missed by 36 percent. Operating income missed by 13 percent.
-
Pre-earnings setup
Expectations were about average.
-
Analyst signal
1 target raise.
-
Earnings quality
Gross margin up 1.4 points. Operating margin up 3.2 points. Positive free cash flow.
Earnings Call Summary
Align reported $1.041 billion in Q1 revenue, up 6.2 percent, with record clear aligner shipments of 686,000 cases. Growth was driven by strong international performance, particularly in EMEA and APAC with double-digit volume increases, while North America remained stable. Management attributed near-term caution to Middle East conflict uncertainty and ongoing macro headwinds affecting consumer demand, but emphasized long-term confidence in digital orthodontics and restorative dentistry expansion through new products like the Invisalign palate expander and treatment planning services.
Guidance Management reaffirmed full year revenue growth of 3 percent to 4 percent and clear aligner volume growth in mid-single digits. They expect Q2 revenue of $1.040 billion to $1.060 billion, up 3 percent to 5 percent year-over-year, with clear aligner volumes up both sequentially and year-over-year.
Slightly positive report. The quarter was acceptable, but the forward setup is not strong.
Insider Buying and Selling at Align Technology, Inc.
Chief Executive Officer Joseph M. Hogan bought 7,576 shares on August 1, 2025, at an average price of $131.49 for a total value of $996,131.0. Later, Chief Financial Officer John Morici sold 7,969 shares on February 18, 2026, at an average price of $189.31 for a total value of $1,508,646.0.
Analysts Set New Price Targets
On October 9, 2026, Stifel maintained a Buy rating with a target of $175.0, moving down from $210.0. Leerink Partners maintained an Outperform rating on October 14, 2026, cutting its target from $235.0 to $215.0. Baird downgraded the stock to Neutral on October 15, 2026, reducing its target from $218.0 to $162.0. Piper Sandler maintained an Overweight rating on October 21, 2026, adjusting its target from $235.0 to $205.0. Overall analyst opinions show a consensus recommendation of a buy with a mean price target of $190.21 across 14 analysts.
About Align Technology, Inc.
Align Technology, Inc. designs and markets clear dental aligners and digital scanners used by orthodontists and dentists around the world. Its core offerings include Invisalign clear aligners, Vivera retainers, and iTero intraoral scanners. Healthcare providers rely on these systems to plan treatments and manufacture custom orthodontic appliances for patients.
Bottom Line
Investors will look toward the company's upcoming earnings report on October 28, 2026, for further clues on business momentum. Market participants continue to weigh updated Wall Street targets against broader healthcare sector trends.
Related Filing Alerts
Source: Mizuho's rating change on $ALGN (Oct 22, 2026). Written by software, not financial advice. How we make alerts